Literature DB >> 8260702

Coordinated inhibition of actin-induced platelet aggregation by plasma gelsolin and vitamin D-binding protein.

C A Vasconcellos1, S E Lind.   

Abstract

Actin is an abundant intracellular protein that is released into the blood during tissue injury and its injection into rats causes microthrombi to form in the vasculature. This report and others have shown that actin filaments are able to aggregate platelets in an adenosine diphosphate (ADP)-dependent manner. The effects on this process of two plasma actin-binding proteins, vitamin D-binding protein (DBP) and gelsolin, were examined separately and together. The addition of DBP, a monomer-binding protein, to actin filaments did not affect their ability to induce platelet aggregation. However, severing of actin filaments with gelsolin resulted in an increased degree of platelet aggregation. Preincubation of F-actin with both gelsolin and DBP resulted in a significant inhibition of aggregation. The effects of DBP and gelsolin on actin-induced aggregation paralleled their effects on exchange of actin-bound adenine nucleotides. DBP inhibited 1, N6-ethenoadenosine 5' triphosphate (epsilon-ATP) exchange with G-actin but not with F-actin. Gelsolin increased epsilon-ATP exchange with F-actin, which was largely abrogated by the addition of DBP. These results suggest that gelsolin's severing (and subsequent capping) of actin filaments not only results in an increase in the number of pointed filament ends but also in the dissociation of actin monomers containing ADP. Phalloidin, which stabilizes actin filaments while decreasing both monomer and nucleotide exchange, inhibited actin-induced aggregation, as well, indicating that depolymerization of actin filaments is not required to inhibit aggregation. Platelet activation by either G- or F-actin may thus be regulated by the local concentrations of the plasma actin-binding proteins gelsolin and DBP. Together, these proteins inhibit platelet aggregation in a manner that can be explained by their effects on actin's filament structure and the accessibility of its bound ADP. Depletion of DBP or gelsolin may allow actin released from injured tissues to stimulate purinergic receptors on platelets, and perhaps other cells, via its bound adenine nucleotides.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8260702

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers.

Authors:  Ana Custodio; Antonio J López-Farré; José J Zamorano-León; Petra J Mateos-Cáceres; Carlos Macaya; Trinidad Caldés; Miguel de la Hoya; Elena Olivera; Javier Puente; Eduardo Díaz-Rubio; Pedro Pérez-Segura
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-07       Impact factor: 4.553

2.  Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease.

Authors:  Yue Liu; Hui-jun Yin; Ke-ji Chen
Journal:  Chin J Integr Med       Date:  2011-08-09       Impact factor: 1.978

3.  Severing of F-actin by the amino-terminal half of gelsolin suggests internal cooperativity in gelsolin.

Authors:  L A Selden; H J Kinosian; J Newman; B Lincoln; C Hurwitz; L C Gershman; J E Estes
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

4.  Visualizing the Ca2+-dependent activation of gelsolin by using synchrotron footprinting.

Authors:  Janna G Kiselar; Paul A Janmey; Steven C Almo; Mark R Chance
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

5.  Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe Outcomes.

Authors:  Wesley H Self; Richard G Wunderink; Mark J DiNubile; Thomas P Stossel; Susan L Levinson; Derek J Williams; Evan J Anderson; Anna M Bramley; Seema Jain; Kathryn M Edwards; Carlos G Grijalva
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 9.079

6.  Plasma proteomic profile associated with platelet dysfunction after trauma.

Authors:  Alexander St John; Yi Wang; Junmei Chen; Warren Osborn; Xu Wang; Esther Lim; Dominic Chung; Susan Stern; Nathan White; Xiaoyun Fu; José López
Journal:  J Thromb Haemost       Date:  2021-04-18       Impact factor: 5.824

7.  BDNFVal66met polymorphism: a potential bridge between depression and thrombosis.

Authors:  Patrizia Amadio; Gualtiero I Colombo; Eva Tarantino; Sara Gianellini; Alessandro Ieraci; Maura Brioschi; Cristina Banfi; José P Werba; Alessandro Parolari; Francis S Lee; Elena Tremoli; Silvia S Barbieri
Journal:  Eur Heart J       Date:  2017-05-07       Impact factor: 29.983

8.  Correlation between Platelet Gelsolin and Platelet Activation Level in Acute Myocardial Infarction Rats and Intervention Effect of Effective Components of Chuanxiong Rhizome and Red Peony Root.

Authors:  Yue Liu; Huijun Yin; Yuerong Jiang; Mei Xue; Chunyu Guo; Dazhuo Shi; Keji Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-07       Impact factor: 2.629

9.  Investigation of the actin scavenging system in pre-eclampsia.

Authors:  Dionne S Tannetta; Christopher W Redman; Ian L Sargent
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-10-25       Impact factor: 2.435

10.  Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas Ligand.

Authors:  Chen-Tzu Chiu; Pei-Wen Wang; Meshach Asare-Werehene; Benjamin K Tsang; Dar-Bin Shieh
Journal:  Cancers (Basel)       Date:  2020-06-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.